Ceftriaxone versus ampicillin for the treatment of community-acquired pneumonia. A propensity matched cohort study

Ceftriaxone is recommended as first-line antibiotic treatment (with the addition of macrolide) for hospitalised adults with community acquired pneumonia (CAP). Narrower-spectrum β-lactam as ampicillin, may be associated with comparable clinical outcomes, with less emergence of resistant pathogens or...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical microbiology and infection 2023-01, Vol.29 (1), p.70-76
Hauptverfasser:	Guz, Dmitri, Bracha, Maayan, Steinberg, Yotam, Kozlovsky, Dror, Gafter-Gvili, Anat, Avni, Tomer
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Ampicillin Ampicillin - therapeutic use Anti-Bacterial Agents - therapeutic use Antibiotic stewardship Ceftriaxone Ceftriaxone - therapeutic use Cohort Studies Community acquired pneumonia Community-Acquired Infections - drug therapy Humans Macrolides - therapeutic use Mortality Pneumonia - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!